[ad_1]
Enter Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous blood glucose monitoring (CGM), today announced that people with diabetes on intensive insulin therapy, aged two years or older, may now be eligible for provincial system coverage. Dexcom G6 SGC through BC PharmaCare. . This extension of coverage is in line with Dexcom’s mission to make it easier for people living with diabetes to experience the benefits of using a CGM system for the management of their diabetes.
“Improved access to CGM technology improves diabetes management for everyone in a patient’s circle of care. As the Endocrinologist and Medical Director of a clinic specifically dedicated to diabetes care, I am grateful that today’s announcement will benefit so many people in the province, ”said Dr. Tom Elliott ‡, Director BC Diabetes Medical Center. CGM provides better blood sugar control for patients1,2 and gives physicians better insight into patient glucose levels to make treatment decisions. Using CMS can reduce the number of emergency room visits by helping users avoid severe hypoglycemic episodes.4
British Columbia joins Yukon, Quebec and Saskatchewan in providing public coverage of CGM systems under provincial health plans. More, Prince Edward Island and Manitoba also recently announced funding plans based on their 2021 budget platforms. For coverage in British Columbia, patients must meet coverage criteria, be enrolled in PharmaCare plans. eligible and meet all franchise requirements. Today’s announcement marks a significant achievement in improving access to life-changing technology used in the management of diabetes and recognizes the impact that CGM technology can have on those who need it. ‘intensive insulin therapy to manage their type 2 diabetes as well as those living with type 1 diabetes.
“As a British Columbia-based company, we are thrilled with today’s announcement and the province’s commitment to the diabetes community,” said Laura Endres, Vice President and General Manager from Dexcom Canada. “We have seen the impact of increased access to CRS to truly change lives, and we look forward to continuing our work towards access for all people affected by diabetes across Canada. “
The Dexcom G6 CGM System includes a small, portable sensor that measures glucose just under the skin; a transmitter for continuously and wirelessly sending glucose levels to a display device; and a smart device * or compatible receiver that displays real-time blood glucose data to users without the need for fingers † or scanning. And with real-time alerts, including an Urgent Low Soon predictive alert, the Dexcom G6 can warn the user of hypoglycemia in advance, giving them time to take appropriate action before it happens. produce, day and night. As part of the BC PharmaCare coverage program, users will now be able to pick up their Dexcom CGM supplies at a participating local pharmacy.
For more information on BC PharmaCare’s coverage criteria, please visit https://www.dexcom.com/en-CA/public-coverage and the section of the BC PharmaCare website regarding Diabetes Supplies.
[ad_2]
Pictures Credit